Humacyte

Humacyte's mission is to become a leader in novel, off-the-shelf extracellular matrix tissue products, especially those that could provide life-saving improvements in treatments for vascular conditions. Because Humacyte grows these tissue replacements in vitro from banked vascular cells that are decellularized, its products do not require cells from the patient and can be easily stored until patients and their surgeons need them. Founded in 2004, Humacyte is a privately held company led by experts in clinical trials, regulatory affairs, business and commercial development, finance and intellectual property management. Humacyte is headquartered in Morrisville, North Carolina.

访问 Humacyte 网站

关于我们

加入我们

  • 登录
  • 成为我们的合作伙伴
  • 成为我们的会员
  • 订阅我们的新闻稿
  • 联系我们

快捷链接

语言版本

隐私政策和服务条款

站点地图

© 2025 世界经济论坛